about
Review of Developments in Electronic, Clinical Data Collection, and Documentation Systems over the Last Decade - Are We Ready for Big Data in Routine Health Care?The Role of Gastrin and CCK Receptors in Pancreatic Cancer and other MalignanciesEpigenetics advancing personalized nanomedicine in cancer therapyData management, documentation and analysis systems in radiation oncology: a multi-institutional surveyNOD-scidIl2rg (tm1Wjl) and NOD-Rag1 (null) Il2rg (tm1Wjl) : a model for stromal cell-tumor cell interaction for human colon cancerPLGA-Loaded Gold-Nanoparticles Precipitated with Quercetin Downregulate HDAC-Akt Activities Controlling Proliferation and Activate p53-ROS Crosstalk to Induce Apoptosis in Hepatocarcinoma Cells.Predicting outcomes in radiation oncology--multifactorial decision support systemsBEAMing up personalized medicine: mutation detection in bloodClinical trial designs incorporating predictive biomarkers.Comparative Effects of CT Imaging Measurement on RECIST End Points and Tumor Growth Kinetics Modeling.Modeling NSCLC progression: recent advances and opportunities availableConcordance of folate receptor-α expression between biopsy, primary tumor and metastasis in breast cancer and lung cancer patients.Estimation of renal cell carcinoma treatment effects from disease progression modelingIn situ Protein Detection for Companion Diagnostics.Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium.Trastuzumab and congestive heart failure: what can we learn from use in the community?Increased Jab1/COPS5 is associated with therapeutic response and adverse outcome in lung cancer and breast cancer patients.Cholecystokinin Receptor-Targeted Polyplex Nanoparticle Inhibits Growth and Metastasis of Pancreatic Cancer.Why the Shift? Taking a Closer Look at the Growing Interest in Niche Markets and Personalized MedicineRecent advances in "smart" delivery systems for extended drug release in cancer therapy
P2860
Q26749385-8D60A8E2-94BB-47E8-9D3B-1EE0E7A5950DQ26765244-E02F0175-B1FE-47C4-B147-31A1F33A66A8Q27010637-6140AF63-0425-407B-8DEB-FCEF9C57058FQ28607400-CB37D203-52F4-4C98-BA03-AB505690DBB4Q33655771-362287F3-71C3-4384-BF00-81DFB18D5509Q35749718-1FCB6C2F-7AEB-4814-86F3-282A26B3632BQ36014711-AA5D429B-B66A-492A-A3D4-43720E0A8780Q36040951-8FB36DF4-48D5-421B-857A-5080D77C0723Q36534713-4F19943D-66FC-49AB-940A-62C40CAD4D1DQ36599208-CCDA8638-EEED-4CDF-AF9D-FBC350A9C7C2Q36910615-0D6EE9B2-545F-4DB8-9C06-7FDBF504D741Q37109499-2BE7A966-5131-4CAB-96B2-8870C5900321Q37217573-DF27201D-32E8-4919-B8C1-477ED9F9C47FQ37270405-598C31B1-33FD-4BB6-BF94-2A1DA824B76DQ38263008-A336D850-1697-4058-9175-1D775E365098Q42868373-04C8D86F-C86A-4F9B-B2F2-7B734E634711Q47153479-70C199AE-DF83-4C60-8DCE-EF84BD39C068Q55223926-ED9A24D8-514D-4398-AE54-A56121DC04F0Q56018113-F1234901-32DA-4097-8F44-687DD90A5AC5Q58735813-1C9B3D3E-99AE-43B5-B2C4-D5503C045262
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Clinical trials in the era of personalized oncology.
@ast
Clinical trials in the era of personalized oncology.
@en
type
label
Clinical trials in the era of personalized oncology.
@ast
Clinical trials in the era of personalized oncology.
@en
prefLabel
Clinical trials in the era of personalized oncology.
@ast
Clinical trials in the era of personalized oncology.
@en
P2860
P356
P1433
P1476
Clinical trials in the era of personalized oncology.
@en
P2093
Michael L Maitland
Richard L Schilsky
P2860
P304
P356
10.3322/CAAC.20135
P407
P577
2011-10-27T00:00:00Z